US 8410089
Fused heterocyclic ring compound
granted A61PA61P1/00A61P1/02
Quick answer
US patent 8410089 (Fused heterocyclic ring compound) held by Takeda Pharmaceutical Company Limited expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/08